CNS Pharmaceuticals, Inc.
USD4.15
+0.00 (+0.00%)
CEO
Rami Levin
IPO Date
2019-11-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.39
Prev. Close
$4.15
Day Low
$4.15
Day High
$4.39
52W Low
$1.90
52W High
$12.36
Market Cap
$0.00B
Volume
0.00M
| -0.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 425.3% | -1108.3% | -0.07 | 0.26 | -0.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -187.8% | -117.0% | 0.05 | 2.55 | -0.2 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -218.9% | -165.5% | 0.06 | 3.50 | -1.3 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -67.8% | -59.7% | 0.03 | 8.13 | -3.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -51.0% | -49.0% | 0.00 | 25.38 | -16.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 1345.7% | -1081.7% | -0.58 | 0.48 | -10.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 899.5% | -324.6% | -2.08 | 0.73 | -142.8 |
| -0.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -32.5% | -27.1% | 0.00 | 5.81 | -0.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -18.1% | -16.4% | 0.01 | 10.22 | -0.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -39.2% | -31.3% | 0.02 | 4.94 | -0.2 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -51.4% | -36.5% | 0.05 | 3.43 | -0.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -167.2% | -75.7% | 0.01 | 1.82 | -0.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 58.9% | -102.5% | -0.03 | 0.32 | -0.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 80.0% | -213.4% | -0.05 | 0.26 | -0.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 121.3% | -316.0% | -0.07 | 0.26 | -0.3 |